Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Janux Therapeutics Inc (JANX)

Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Janux Therapeutics Inc 10955 Vista Sorrento Parkway Suite 200 San Diego CA 92130 USA

www.januxrx.com Employees: 64 P: 858-751-4493

Description:

Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies. Janux Therapeutics Inc. is based in LA JOLLA, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,982,552
Enterprise Value, $K 2,963,342
Shares Outstanding, K 52,482
Annual Sales, $ 8,080 K
Annual Net Income, $ -58,290 K
Last Quarter Sales, $ 440 K
Last Quarter Net Income, $ -28,060 K
EBIT, $ -85,960 K
EBITDA, $ -91,690 K
60-Month Beta 3.29
% of Insider Shareholders 29.40%
% of Institutional Shareholders 75.39%
Float, K 37,052
% Float 70.60%
Short Volume Ratio 0.73

Growth:

1-Year Return 496.33%
3-Year Return 165.07%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.51 on 11/06/24
Next Earnings Date 11/05/24
Earnings Per Share ttm -1.17
EPS Growth vs. Prev Qtr -363.64%
EPS Growth vs. Prev Year -104.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

JANX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.46%
Return-on-Assets % -9.86%
Profit Margin % -721.41%
Debt/Equity 0.00
Price/Sales 368.47
Price/Cash Flow N/A
Price/Book 4.51
Book Value/Share 12.58
Interest Coverage -1.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar